• 벤처혁신연구
• /
• 제5권4호
• /
• pp.157-178
• /
• 2022

COVID-19로 인해 전 세계적으로 경제는 악화되었으며 국내 역시 큰 타격을 받게 되었다. 이에 정부는 중소기업들이 겪고 있는 자금난 해소를 위해 전례 없는 COVID-19 관련 재정지원 정책을 시행하였다. 또한, 정부는 COVID-19 확산이 지속되자 비대면 접촉을 권고했으며 그에 따른 지침과 방안을 내세움에 따라 공공부문과 민간부문의 조직들은 비대면 형태의 업무방식을 도입하였다. 이러한 상황을 고려하여 본 연구는 COVID-19 관련 재정지원 정책이 중소기업의 혁신에 미치는 영향을 규명하였다. 또한, 기업의 혁신을 위해서는 정부의 지원과 같은 외부적인 지원도 중요하나 내부적 역량 역시 중요한 요인에 해당한다. 따라서 기업가정신이 제품혁신에 미치는 영향을 파악하였으며, 더하여 비대면 형태의 업무방식이 활성화됨에 따라 스마트워크를 도입한 기업과 도입하지 않는 기업 간 비교를 통해 스마트워크의 효과를 파악하였다. 가설검증을 위한 자료수집은 과학기술정책연구원에서 제공하는 한국기업혁신조사-2020년 (제조업)의 자료를 활용하였다. 또한, 가설검증을 위해 성향점수매칭을 이용해 표본에 대한 선택편의를 줄인 이후 스마트 도입 기업과 도입하지 않은 기업 간 집단을 분류하여 다중회귀분석을 시행하였다. 분석결과는 다음과 같다. 기업가정신의 경우 스마트워크 도입 여부에 상관없이 중소기업의 제품혁신에 정(+)의 영향을 미쳤다. COVID-19 재정지원정책의 경우, 금융지원은 스마트워크를 도입한 기업에게만 제품혁신에 정(+)의 영향을 미쳤으며 이외에 지원정책은 스마트워크 도입 여부에 상관없이 제품혁신에는 효과가 없는 것으로 나타났다. 분석결과 기업가정신은 스마트워크 도입 여부에 상관없이 정(+)의 영향을 나타냈으며, COVID-19 관련 재정지원정책은 지원유형에 따라 혼재된 결과를 보여주는 것으로 나타났다. 이러한 분석결과를 토대로 정책적 및 학문적 시사점을 제시할 수 있었다.

• Korean Journal of Radiology
• /
• 제24권12호
• /
• pp.1284-1292
• /
• 2023

Objective: We investigated the impacts of computed tomography (CT) added to ultrasound (US) for preoperative evaluation of patients with papillary thyroid carcinoma (PTC) on staging, surgical extent, and postsurgical survival. Materials and Methods: Consecutive patients who underwent surgery for PTC between January 2015 and December 2015 were retrospectively identified. Of them, 584 had undergone preoperative additional thyroid CT imaging (CT + US group), and 859 had not (US group). Inverse probability of treatment weighting (IPTW) and propensity score matching (PSM) were used to adjust for 14 variables and balance the two groups. Changes in nodal staging and surgical extent caused by CT were recorded. The recurrence-free survival and distant metastasis-free survival after surgery were compared between the two groups. Results: In the CT + US group, discordant nodal staging results between CT and US were observed in 94 of 584 patients (16.1%). Of them, CT accurately diagnosed nodal staging in 54 patients (57.4%), while the US provided incorrect nodal staging. Ten patients (1.7%) had a change in the extent of surgery based on CT findings. Postsurgical recurrence developed in 3.6% (31 of 859) of the CT + US group and 2.9% (17 of 584) of the US group during the median follow-up of 59 months. After adjustment using IPTW (580 vs. 861 patients), the CT + US group showed significantly higher recurrence-free survival rates than the US group (hazard ratio [HR], 0.52 [95% confidence interval {CI}, 0.29-0.96]; P = 0.037). PSM analysis (535 patients in each group) showed similar HR without statistical significance (HR, 0.60 [95% CI, 0.31-1.17]; P = 0.134). For distant metastasis-free survival, HRs after IPTW and PSM were 0.75 (95% CI, 0.17-3.36; P = 0.71) and 0.87 (95% CI, 0.20-3.80; P = 0.851), respectively. Conclusion: The addition of CT imaging for preoperative evaluation changed nodal staging and surgical extent and might improve recurrence-free survival in patients with PTC.

• 대한임상독성학회지
• /
• 제21권2호
• /
• pp.117-127
• /
• 2023

Purpose: No consensus currently exists regarding the maximal pressure of hyperbaric oxygen (HBO₂) therapy performed within 24 hours of acute carbon monoxide (CO) poisoning. This study aimed to evaluate the difference in therapeutic effects according to the first HBO₂ pressure (3.0 atmospheres absolute [ATA] vs. 2.8 ATA). Methods: We used prospectively collected registry data on CO poisoning at a tertiary academic hospital in the Republic of Korea. Adult patients with acute CO poisoning treated with HBO₂ within 24 hours after arrival at the emergency department and without the use of additional HBO₂ after 24 hours between January 2007 and February 2022 were included. Data from 595 patients were analyzed using propensity score matching (PSM). Patients with mild (non-intubated) and severe (intubated) poisoning were also compared. Neurocognitive outcomes at 1 month after CO poisoning were evaluated using the Global Deterioration Scale combined with neurological impairment. Results: After PSM, the neurocognitive outcomes at 1-month post-CO exposure were not significantly different between the 2.8 ATA (110 patients) and 3.0 ATA (55 patients) groups (p=1.000). Similarly, there was also no significant difference in outcomes in a subgroup analysis according to poisoning severity in matched patients (165 patients) (mild [non-intubated]: p=0.053; severe [intubated]: p=1.000). Conclusion: Neurocognitive sequelae at 1 month were not significantly different between HBO₂ therapy pressures of 2.8 ATA and 3.0 ATA in patients with acute CO poisoning. In addition, the 1-month neurocognitive sequelae did not differ significantly between intubated and non-intubated patients.